Clinical Trial Update: Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating apremilast for frontal fibrosing alopecia; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontal Fibrosing Alopecia

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Bellevue Dermatology | Conditions: Frontal Fibrosing Alopecia | Phase 4 | Status: UNKNOWN